Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History BMRA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics BMRA

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Biomerica Inc

BMRA
Current price
3.40 USD +0.13 USD (+3.98%)
Last closed 3.27 USD
ISIN US09061H3075
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 8 324 635 USD
Yield for 12 month -0.75 %
1Y
3Y
5Y
10Y
15Y
BMRA
21.11.2021 - 28.11.2021

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops, markets, and sells COVID-19 diagnostic tests to indicate if a person has been infected by COVID-19. The company was incorporated in 1971 and is headquartered in Irvine, California. Address: 17571 Von Karman Avenue, Irvine, CA, United States, 92614

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

13.00 USD

P/E Ratio

Dividend Yield

Financials BMRA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures BMRA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+5 415 000 USD

Last Year

+5 339 000 USD

Current Quarter

+1 119 000 USD

Last Quarter

+1 636 000 USD

Current Year

+611 000 USD

Last Year

+446 000 USD

Current Quarter

+19 000 USD

Last Quarter

+437 000 USD
EBITDA -5 015 000 USD
Operating Margin TTM -108.13 %
Price to Earnings
Return On Assets TTM -35.99 %
PEG Ratio
Return On Equity TTM -72.70 %
Wall Street Target Price 13.00 USD
Revenue TTM 5 678 000 USD
Book Value 2.17 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 10.00 %
Dividend Yield
Gross Profit TTM 762 000 USD
Earnings per share -2.16 USD
Diluted Eps TTM -2.16 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -85.42 %

Stock Valuation BMRA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.01
Price Sales TTM 1.47
Enterprise Value EBITDA -5.42
Price Book MRQ 1.49

Technical Indicators BMRA

For 52 Weeks

1.93 USD 8.80 USD
50 Day MA 3.38 USD
Shares Short Prior Month 47 862
200 Day MA 3.62 USD
Short Ratio 1.63
Shares Short 53 067
Short Percent 2.22 %